Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis

CONCLUSION: Our meta-analysis confirmed that the increased number of CPCs had a negative impact on the PFS and OS of MM patients. Therefore, CPCs could be a promising prognostic biomarker that helps with risk stratification and disease monitoring.PMID:38599340 | PMC:PMC11008311 | DOI:10.1080/07853890.2024.2338604
Source: Annals of Medicine - Category: Internal Medicine Authors: Source Type: research